SHANGHAI, China, Jan. 6 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. , a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced that Dr. Ge Li, the Company’s Chairman and Chief Executive Officer, will present at the 28th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2010, at 4:00 pm Pacific Standard Time.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
The Company will broadcast its presentation. The public may access the broadcast through the Investor Relations section of the Company’s web site: http://www.wuxiapptec.com .
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech’s services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. WuXi PharmaTech’s operating subsidiaries are known as WuXi AppTec. For more information, please visit: http://www.wuxiapptec.com .
CONTACT: Ronald Aldridge, Director of Investor Relations, WuXi PharmaTech
(Cayman) Inc., +1-201-585-2048, or Ron_Aldridge@wuxiapptec.com; or
Stephanie Liu (for the media), WuXi PharmaTech (Cayman) Inc.,
+86-21-5046-4362, or pr@wuxiapptec.com
Web site: http://www.wuxiapptec.com/
